Tanvex received marketing authorization from Health Canada Oct.17,2021 Oct.04,2021 FDA Accepts TX05 BLA Filing Read More Jun.28,2023 Tanvex Accelerates CDMO Layout to Expand Business Opportunities Read More Jul.11,2024 Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen - GeneOnline News Read More